Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTGTGTAAACAATACCTGAACCTTTACCCCGTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCA| |TGGGCCATCAGCGCATGCGTGGAACCTTTTCGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAA
End
27737931/27247023 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/6847669; hsa-let-7e/Downstream/7875677;
Upstream sequence
cagaagaattgtcagtaacctccttttgttttgtggattcaacccacagagatgaacattcctttagacagagcagatttcaaacacactttttgtggaa
Downstream sequence
tttgcaagtggagatttcaagcgctttgaggccaattgtagaaaaggaaatatcttcgtataaaagctagacagaatgattcccagaaactgcgttgtga
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.